» Articles » PMID: 33211495

Lysozyme Membranes Promoted by Hydrophobic Substrates for Ultrafast and Precise Organic Solvent Nanofiltration

Overview
Journal Nano Lett
Specialty Biotechnology
Date 2020 Nov 19
PMID 33211495
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Organic solvent nanofiltration (OSN) is regarded as a promising separation technology in chemical and pharmaceutical industries. However, it remains a great challenge in fabricating OSN membranes with high permeability and precise selectivity by simple, transfer-free, and up-scalable processes. Herein, we report lysozyme nanofilm composite membranes (LNCM) prepared by one-step methods with hydrophobic substrates at the air/water interface. The microporous substrates not only promote the heterogeneous nucleation of amyloid-like lysozyme oligomers to construct small pores in the formed nanofilms but also benefit for the simultaneous composition of LNCM via hydrophobic interactions. The constructed nanopores are reduced to around 1.0 nm, and they are demonstrated by grazing incidence small-angle X-ray scattering with a closely packed model. The LNCM can tolerate most organic polar solvents and the permeability surpasses most of state-of-the-art OSN membranes.

Citing Articles

Turing covalent organic framework membranes via heterogeneous nucleation synthesis for organic solvent nanofiltration.

Yang F, Guo J, Han C, Huang J, Zhou Z, Sun S Sci Adv. 2024; 10(50):eadr9260.

PMID: 39661688 PMC: 11633759. DOI: 10.1126/sciadv.adr9260.


Microporous polyarylate membranes based on 3D phenolphthalein for molecular sieving.

Yao A, Hou J, Dou P, Du J, Sun Q, Song Z Sci Adv. 2024; 10(32):eado7687.

PMID: 39121217 PMC: 11313862. DOI: 10.1126/sciadv.ado7687.


Non-fibril amyloid aggregation at the air/water interface: self-adaptive pathway resulting in a 2D Janus nanofilm.

Ren H, Chen H, Kang Y, Liu W, Liu Y, Tao F Chem Sci. 2024; 15(23):8946-8958.

PMID: 38873054 PMC: 11168098. DOI: 10.1039/d4sc00560k.


Organic Solvent Nanofiltration in Pharmaceutical Applications.

Xiao H, Feng Y, Goundry W, Karlsson S Org Process Res Dev. 2024; 28(4):891-923.

PMID: 38660379 PMC: 11036530. DOI: 10.1021/acs.oprd.3c00470.


Exploring the therapeutic potential of recombinant human lysozyme: a review on wound management system with antibacterial.

Zhao M, Huang M, Li Z Front Bioeng Biotechnol. 2023; 11:1292149.

PMID: 38026866 PMC: 10646323. DOI: 10.3389/fbioe.2023.1292149.